Nov 12, 2026
This research is important because it highlights potential complications in treating patients with HHT and endocarditis and may influence discussions between patients and their healthcare providers about managing surgical risks and bleeding issues.
This study aims to explore the risks of surgery in patients with hereditary hemorrhagic telangiectasia (HHT) who have endocarditis, which is an infection of the heart's inner lining, and unusual bleeding issues.
Results are not yet available as the full findings have not been published yet.
The researchers analyze cases of patients with HHT who developed endocarditis, focusing on their surgical outcomes and bleeding tendencies.
Since no specific results are available and details are limited, we can't determine the effectiveness or safety of surgical procedures in these cases. Additionally, this topic is still being investigated with more studies needed.
For your doctor:
PMID: 43018153
DOI: 10.33963/v.phj.115734